Sirolimus 2 mg    (DrugBank: Sirolimus)

1 disease
IDDisease name (Link within this page)Number of trials
17Multiple system atrophy1

17. Multiple system atrophy    [ 107 clinical trials,   153 drugs,   (DrugBank: 48 drugs),   59 drug target genes,   104 drug target pathways]
Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 107 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03589976
(ClinicalTrials.gov)
September 1, 20185/7/2018A Futility Trial of Sirolimus in Multiple System AtrophyA Single Center Randomized,Double Blind, Placebo-controlled Futility Trial to Determine if Sirolimus is of Sufficient Promise to Slow the Progression of Multiple System AtrophyMultiple System AtrophyDrug: Sirolimus 2 MG;Other: PlaceboNYU Langone HealthNational Institute of Neurological Disorders and Stroke (NINDS)Recruiting30 Years80 YearsAll56Phase 2United States